MedPath

Intralipid

Intralipid 30% (A 30% I.V. Fat Emulsion)

Approved
Approval ID

dd269651-30e8-43f0-880f-484346eaafeb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 21, 2022

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

I. V. Fat Emulsion

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0338-0520
Application NumberNDA019942
Product Classification
M
Marketing Category
C73594
G
Generic Name
I. V. Fat Emulsion
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 21, 2022
FDA Product Classification

INGREDIENTS (4)

GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
EGG PHOSPHOLIPIDSInactive
Code: 1Z74184RGV
Classification: IACT
SOYBEAN OILActive
Quantity: 30 g in 100 mL
Code: 241ATL177A
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Intralipid - FDA Drug Approval Details